245 related articles for article (PubMed ID: 2459295)
1. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.
Townsend A; Bastin J; Gould K; Brownlee G; Andrew M; Coupar B; Boyle D; Chan S; Smith G
J Exp Med; 1988 Oct; 168(4):1211-24. PubMed ID: 2459295
[TBL] [Abstract][Full Text] [Related]
2. Differential processing and presentation of the H-2D(b)-restricted epitope from two different strains of influenza virus nucleoprotein.
Potter P; Tourdot S; Blanchard T; Smith GL; Gould KG
J Gen Virol; 2001 May; 82(Pt 5):1069-1074. PubMed ID: 11297681
[TBL] [Abstract][Full Text] [Related]
3. Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes.
Blake NW; Kettle S; Law KM; Gould K; Bastin J; Townsend AR; Smith GL
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2393-8. PubMed ID: 7561783
[TBL] [Abstract][Full Text] [Related]
4. Characterization of two distinct major histocompatibility complex class I Kk-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutinin.
Gould KG; Scotney H; Brownlee GG
J Virol; 1991 Oct; 65(10):5401-9. PubMed ID: 1716691
[TBL] [Abstract][Full Text] [Related]
5. A 15 amino acid fragment of influenza nucleoprotein synthesized in the cytoplasm is presented to class I-restricted cytotoxic T lymphocytes.
Gould K; Cossins J; Bastin J; Brownlee GG; Townsend A
J Exp Med; 1989 Sep; 170(3):1051-6. PubMed ID: 2475569
[TBL] [Abstract][Full Text] [Related]
6. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein.
Yellen-Shaw AJ; Wherry EJ; Dubois GC; Eisenlohr LC
J Immunol; 1997 Apr; 158(7):3227-34. PubMed ID: 9120278
[TBL] [Abstract][Full Text] [Related]
7. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response.
Coupar BE; Andrew ME; Both GW; Boyle DB
Eur J Immunol; 1986 Dec; 16(12):1479-87. PubMed ID: 3493144
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the contribution of CTL epitopes in the immunobiology of morbillivirus infection.
Beauverger P; Cardoso AI; Daviet L; Buckland R; Wild TF
Virology; 1996 May; 219(1):133-9. PubMed ID: 8623522
[TBL] [Abstract][Full Text] [Related]
9. Recognition by major histocompatibility complex class I-restricted cytolytic T lymphocytes of cells expressing vaccinia-encoded viral and class I proteins.
Andrew ME; Coupar BE; Boyle DB; Blanden RV
Eur J Immunol; 1987 Oct; 17(10):1515-8. PubMed ID: 3500060
[TBL] [Abstract][Full Text] [Related]
10. No recognition of MHC class II+ cells infected with a vaccinia virus encoding influenza type A nucleoprotein by class II-restricted T cells.
Freer G; Senesi S
Immunol Lett; 1993 Jun; 36(3):305-12. PubMed ID: 8370602
[TBL] [Abstract][Full Text] [Related]
11. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice.
Wild TF; Bernard A; Spehner D; Drillien R
J Gen Virol; 1992 Feb; 73 ( Pt 2)():359-67. PubMed ID: 1538193
[TBL] [Abstract][Full Text] [Related]
12. High peptide affinity for MHC class I does not correlate with immunodominance.
Müllbacher A; Lobigs M; Yewdell JW; Bennink JR; Tha Hla R; Blanden RV
Scand J Immunol; 1999 Oct; 50(4):420-6. PubMed ID: 10520183
[TBL] [Abstract][Full Text] [Related]
13. HLA class I molecules consistently present internal influenza epitopes.
Wahl A; Schafer F; Bardet W; Buchli R; Air GM; Hildebrand WH
Proc Natl Acad Sci U S A; 2009 Jan; 106(2):540-5. PubMed ID: 19122146
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of influenza haemagglutinin and nucleoprotein as protective antigens against influenza virus infection in mice.
Andrew ME; Coupar BE
Scand J Immunol; 1988 Jul; 28(1):81-5. PubMed ID: 2456608
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the specificity of cytotoxic T lymphocytes for the nucleoprotein of Pichinde virus using recombinant vaccinia viruses.
Ozols DY; Harnish DG; Rawls WE; Rosenthal KL
Arch Virol; 1990; 115(3-4):209-25. PubMed ID: 1701987
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants.
Andrew ME; Coupar BE; Ada GL; Boyle DB
Microb Pathog; 1986 Oct; 1(5):443-52. PubMed ID: 3509883
[TBL] [Abstract][Full Text] [Related]
17. Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens.
Fu TM; Guan L; Friedman A; Ulmer JB; Liu MA; Donnelly JJ
Vaccine; 1998 Nov; 16(18):1711-7. PubMed ID: 9778746
[TBL] [Abstract][Full Text] [Related]
18. Epitope-specific cytotoxic T lymphocyte induction by minigene DNA immunization.
Iwasaki A; Dela Cruz CS; Young AR; Barber BH
Vaccine; 1999 Apr; 17(15-16):2081-8. PubMed ID: 10217610
[TBL] [Abstract][Full Text] [Related]
19. Class I MHC-restricted cytotoxic T cells efficiently recognize haemagglutinin that is defective in protein folding and cell surface expressions.
Jennings PA; Boyle DB; Andrew ME
Mol Immunol; 1988 Dec; 25(12):1371-6. PubMed ID: 2467191
[TBL] [Abstract][Full Text] [Related]
20. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
